Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing

摘要

BackgroundThe implementation of liquid biopsy for biomarker testing and response to treatment monitoring in cancer patients would presumable increase laboratory throughput, requiring the development of automated methods for circulating free DNA (cfDNA) isolation.